A group of health professionals has gone to court against the FDA and HHS in an attempt to overturn the unlawful ban on using ivermectin to cure COVID-19.
In a June 2 court filing, attorneys for Doctors Mary Talley Bowden, Robert L. Apter, and Paul E. Marik said that the U.S. FDA does not have the authority to order public health experts and patients to cease taking ivermectin as a COVID-19 therapy. Their civil complaint against HHS Sec. Xavier Becerra and the FDA Commissioner Robert M. Califf claims that the government has illegally banned an authorized drug from “off-label” usage.
“The FDA is also unable to advise patients whether or not they should take an authorized medicine for a certain purpose. These matters are in the scope of the doctor-patient relationship,” according to the complaint. “Attempts by the FDA to interfere or influence in the doctor-patient relationship is intruding into the practice of medicine, which is — and has always been — regulated solely by states.”
The FDA’s actions, according to the lawsuit, include “numerous examples of formal, clear, and conclusive actions” to “prohibit or otherwise obstruct the usage of ivermectin to help with treatment of COVID-19.”
A Dec. 10, 2021, FDA article called “Why You Shouldn’t Use Ivermectin to Prevent orTreat COVID-19” claims that the agency has not given approval for ivermectin usage in treating or preventing COVID-19.
The FDA also stated that some people who took ivermectin to treat COVID ended up requiring medical treatment, including hospitalization, after overdosing on a livestock version of the medication. The lawsuit also referred to a tweet from the FDA in which it said, “You aren’t a horse or a cow. Seriously, folks. Stop it.”
COVID-19 has been studied extensively and yet no studies have found that ivermectin, a medicine licensed to treat parasites, is an effective treatment.
While the doctors disagree, the lawsuit makes it clear that the court is not being asked to decide whether ivermectin is a successful COVID-19 therapy.
The lawsuit “goes to the heart of who has the authority to decide which treatment is best for each individual person and if the FDA can interfere,” according to the complaint.